Aspire-Lakewood Holdings, Inc. (ASBP)
| Market Cap | 10.25M -45.9% |
| Revenue (ttm) | 97,659 |
| Net Income | -11.05M |
| EPS | -33.33 |
| Shares Out | 1.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,950 |
| Open | 7.22 |
| Previous Close | 7.27 |
| Day's Range | 7.20 - 7.43 |
| 52-Week Range | 3.31 - 431.88 |
| Beta | 0.17 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 17, 2026 |
About ASBP
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lead prescription product candidate, Sublingual High Dose Aspirin, targets pain management and anti-inflammatory applications. The co... [Read more]
Financial Performance
Financial StatementsNews
Aspire-Lakewood Holdings approves $10M share repurchase program
Aspire-Lakewood announced the Board authorized a $10M common stock repurchase program. This expanded share repurchase program is effective September 9, 2026. The expanded authorization reflects the Co...
Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program
Brings total authorized repurchase to $10 million Reflects leadership's view that Aspire-Lakewood's share price does not reflect the Company's financial strength or long-term growth opportunity Increa...
Aspire Biopharma announces changes corporate name to Aspire-Lakewood
Aspire Biopharma announced that it has changed its corporate name from “Aspire Biopharma” to “Aspire-Lakewood Holdings (ASBP).” The name change is effective upon the filing of a Certificate of Amendme...
Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc.
ESTERO, FL / ACCESS Newswire / September 8, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it has changed its corporate name from "Aspire Biopha...
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings...
Aspire Biopharma completes acquisition of Dura Driver Control Systems
Aspire Biopharma (ASBP) announced that the Company has completed its previously announced acquisition of Dura Driver Control Systems. The acquisition is expected to enhance Aspire’s ability to deliver...
Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue
Acquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterprise Adds an established global brand with scale in large...
Aspire Biopharma Holdings Inc trading resumes
12:25 EDT Aspire Biopharma (ASBP) Holdings Inc trading resumes
Aspire Biopharma Holdings Inc trading halted, volatility trading pause
12:20 EDT Aspire Biopharma (ASBP) Holdings Inc trading halted, volatility trading pause
Aspire Biopharma appoints Jarryd McNeil as sponsored athlete for BUZZ BOMB
Aspire Biopharma (ASBP) has named multi-time X Games medalist and freestyle motocross legend Jarryd McNeil as a sponsored athlete for its BUZZ BOMB caffeine product line. McNeil will integrate BUZZ…
Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)
High-Octane Partnership: Multi-time X Games medalist Jarryd McNeil joins BUZZ BOMB™ to fuel brand expansion in action sports. Consumer Connection: The collaboration strengthens BUZZ BOMB™'s commitment...
Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs
The brand expands nationwide distribution on Amazon, delivering a waterless, rapid-dissolve 50 mg caffeine powder built for active, on-the-go lifestyles. ESTERO, FL / ACCESS Newswire / June 24, 2026 /...
Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th
ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.'s (Nasdaq: ASBP) (“Aspire” or the “Company”), today announced that it will present live at the Life Sciences Investor Fo...
Aspire Biopharma Holdings Inc trading resumes
14:17 EDT Aspire Biopharma (ASBP) Holdings Inc trading resumes
Aspire Biopharma Holdings Inc trading halted, volatility trading pause
14:07 EDT Aspire Biopharma (ASBP) Holdings Inc trading halted, volatility trading pause
Aspire Biopharma signs definitive SPA to acquire Dura Driver Control Systems
Aspire Biopharma (ASBP) announced the signing of a definitive Share Purchase Agreement for the acquisition of 100% of Dura Driver Control Systems, a designer and manufacturer of automotive driver cont...
Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue
Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systems Acquisition significantly accelerates Aspire's revenue, earnings growt...
Aspire Biopharma issues letter to shareholders
Aspire Biopharma (ASBP) issued the following letter to shareholders from Chief Executive Officer Kraig Higginson. “2026 is shaping up to be a defining year for Aspire Biopharma Holdings. We are…
Aspire Biopharma Issues Shareholder Letter
ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delive...
Aspire Biopharma’s Buzz Bomb partners with EoS Fitness
Aspire Biopharma (ASBP) subsidiary Buzz Bomb Caffeine Company announces a strategic partnership with EoS Fitness. Through the EoS Flex Deals affiliate program, BUZZ BOMB’s lineup of 50mg sublingual ca...
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members
ESTERO, FL / ACCESS Newswire / May 27, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC is proud to announce a s...
Aspire Biopharma Holdings Inc trading halted, news pending
19:50 EDT Aspire Biopharma (ASBP) Holdings Inc trading halted, news pending
Aspire Biopharma to effect 1-for-30 reverse stock split
Aspire Biopharma (ASBP) will effect a one-for-thirty reverse stock split of its common stock, par value $0.0001 per share, that will become effective on May 11, 2026, at 12:01 AM…
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today an...
Aspire Biopharma announces $5M share repurchase plan
Aspire Biopharma (ASBP) Holdings announced that its Board of Directors has authorized the repurchase of up to $5M of the Company’s common stock